Table of Contents

company-logo

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was formerly known as Brickell Biotech, Inc. and changed its name to Fresh Tracks Therapeutics, Inc. in September 2022. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.

Fresh Tracks Therapeutics Dividend Announcement

• Fresh Tracks Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Fresh Tracks Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Fresh Tracks Therapeutics Dividend History

Fresh Tracks Therapeutics Dividend Yield

Fresh Tracks Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Fresh Tracks Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Fresh Tracks Therapeutics Financial Ratios

P/E ratio-3.00
PEG ratio0.11
P/B ratio0.43
ROE-14.73%
Payout ratio0.00%
Current ratio6.98
Quick ratio6.98
Cash Ratio6.56

Fresh Tracks Therapeutics Dividend FAQ

Does Fresh Tracks Therapeutics stock pay dividends?
Fresh Tracks Therapeutics does not currently pay dividends to its shareholders.
Has Fresh Tracks Therapeutics ever paid a dividend?
No, Fresh Tracks Therapeutics has no a history of paying dividends to its shareholders. Fresh Tracks Therapeutics is not known for its dividend payments.
Why doesn't Fresh Tracks Therapeutics pay dividends?
There are several potential reasons why Fresh Tracks Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Fresh Tracks Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Fresh Tracks Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Fresh Tracks Therapeutics a dividend aristocrat?
Fresh Tracks Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Fresh Tracks Therapeutics a dividend king?
Fresh Tracks Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Fresh Tracks Therapeutics a dividend stock?
No, Fresh Tracks Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Fresh Tracks Therapeutics stocks?
To buy Fresh Tracks Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Fresh Tracks Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.